Format
Sort by
Items per page

Send to

Choose Destination

Best matches for fees and charges AND incentives AND medicare:

Measuring coding intensity in the Medicare Advantage program. Kronick R et al. Medicare Medicaid Res Rev. (2014)

Bundling post-acute care services into MS-DRG payments. Vertrees JC et al. Medicare Medicaid Res Rev. (2013)

The affordable care ACT on loyalty programs for federal beneficiaries. Piacentino JJ et al. J Pharm Pract. (2014)

Search results

Items: 1 to 20 of 175

1.

Association Between Extending CareFirst's Medical Home Program to Medicare Patients and Quality of Care, Utilization, and Spending.

Peterson GG, Geonnotti KL, Hula L, Day T, Blue L, Kranker K, Gilman B, Stewart K, Hoag S, Moreno L.

JAMA Intern Med. 2017 Sep 1;177(9):1334-1342. doi: 10.1001/jamainternmed.2017.2775.

PMID:
28759685
2.

An Overview of Home-Based Primary Care: Learning from the Field.

Klein S, Hostetter M, McCarthy D.

Issue Brief (Commonw Fund). 2017 Jun;15:1-20.

PMID:
28591975
3.

Mind the Gap: Hospitalizations from Multiple Sources in a Longitudinal Study.

Savitz ST, Stearns SC, Groves JS, Kucharska-Newton AM, Bengtson LGS, Wruck L.

Value Health. 2017 Jun;20(6):777-784. doi: 10.1016/j.jval.2016.04.012. Epub 2016 Jun 9.

PMID:
28577695
4.

Hospital Characteristics Associated With Risk-standardized Readmission Rates.

Horwitz LI, Bernheim SM, Ross JS, Herrin J, Grady JN, Krumholz HM, Drye EE, Lin Z.

Med Care. 2017 May;55(5):528-534. doi: 10.1097/MLR.0000000000000713.

PMID:
28319580
5.

Improving Hospital Incentives with Better Cost Data.

Ederhof M, Ginsburg PB.

N Engl J Med. 2017 Mar 16;376(11):1010-1011. doi: 10.1056/NEJMp1613181. No abstract available.

PMID:
28296605
6.

Evaluating the Effects of Pioneer Accountable Care Organizations on Medicare Part D Drug Spending and Utilization.

Zhang Y, Caines KJ, Powers CA.

Med Care. 2017 May;55(5):470-475. doi: 10.1097/MLR.0000000000000686.

PMID:
28060052
7.

Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform.

Erickson KF, Winkelmayer WC, Chertow GM, Bhattacharya J.

Am J Kidney Dis. 2017 Feb;69(2):237-246. doi: 10.1053/j.ajkd.2016.08.033. Epub 2016 Nov 14.

PMID:
27856087
8.

Future considerations for clinical dermatology in the setting of 21st century American policy reform: Accountable Care Organizations.

Nguyen HP, Barbieri JS, Forman HP, Bolognia JL, VanBeek MJ; Group for Research of Policy Dynamics in Dermatology.

J Am Acad Dermatol. 2017 Jan;76(1):170-176. doi: 10.1016/j.jaad.2016.07.063. Epub 2016 Oct 1.

PMID:
27707589
9.

Characteristics and Service Use of Medicare Beneficiaries Using Federally Qualified Health Centers.

Chang CH, Lewis VA, Meara E, Lurie JD, Bynum JP.

Med Care. 2016 Aug;54(8):804-9. doi: 10.1097/MLR.0000000000000564.

10.

Pharmaceutical Policy Reform--Balancing Affordability with Incentives for Innovation.

Conti RM, Rosenthal MB.

N Engl J Med. 2016 Feb 25;374(8):703-6. doi: 10.1056/NEJMp1515068. No abstract available.

11.

Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care.

O'Neil B, Graves AJ, Barocas DA, Chang SS, Penson DF, Resnick MJ.

J Natl Cancer Inst. 2015 Nov 18;108(2). pii: djv331. doi: 10.1093/jnci/djv331. Print 2016 Feb.

PMID:
26582063
12.

Do geographic variations signify overuse?

Gourin CG.

Otolaryngol Head Neck Surg. 2015 Jun;152(6):991-2. doi: 10.1177/0194599815583477. No abstract available.

PMID:
26034100
13.

Hospital readmissions reduction program.

McIlvennan CK, Eapen ZJ, Allen LA.

Circulation. 2015 May 19;131(20):1796-803. doi: 10.1161/CIRCULATIONAHA.114.010270. No abstract available.

14.

Medicare's Bundled Payment initiative: most hospitals are focused on a few high-volume conditions.

Tsai TC, Joynt KE, Wild RC, Orav EJ, Jha AK.

Health Aff (Millwood). 2015 Mar;34(3):371-80. doi: 10.1377/hlthaff.2014.0900.

PMID:
25732486
15.

Treating age-related macular degeneration: comparing the use of two drugs among medicare and veterans affairs populations.

Pershing S, Pal Chee C, Asch SM, Baker LC, Boothroyd D, Wagner TH, Bundorf MK.

Health Aff (Millwood). 2015 Feb;34(2):229-38. doi: 10.1377/hlthaff.2014.1032. Erratum in: Health Aff (Millwood). 2015 Mar 1;34(3):540.

PMID:
25646102
16.

Avoiding unintended incentives in ACO payment models.

Douven R, McGuire TG, McWilliams JM.

Health Aff (Millwood). 2015 Jan;34(1):143-9. doi: 10.1377/hlthaff.2014.0444.

PMID:
25561655
17.

Effects of lifestyle modification programs on cardiac risk factors.

Razavi M, Fournier S, Shepard DS, Ritter G, Strickler GK, Stason WB.

PLoS One. 2014 Dec 9;9(12):e114772. doi: 10.1371/journal.pone.0114772. eCollection 2014.

18.

A case study in generic drug use: should there be risk adjustment in incentive payments for the use of generic medications?

Walton SM, Rash C, Lambert BL, Galanter WL.

J Manag Care Spec Pharm. 2014 Nov;20(11):1093-9.

19.

Advanced imaging among health maintenance organization enrollees with cancer.

Loggers ET, Fishman PA, Peterson D, O'Keeffe-Rosetti M, Greenberg C, Hornbrook MC, Kushi LH, Lowry S, Ramaprasan A, Wagner EH, Weeks JC, Ritzwoller DP.

J Oncol Pract. 2014 Jul;10(4):231-8. doi: 10.1200/JOP.2013.001258. Epub 2014 May 20.

20.

Accountable care organizations and the allergist: challenges and opportunities.

Ein D, Foggs MB.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):34-9. doi: 10.1016/j.jaip.2013.09.020.

PMID:
24565766

Supplemental Content

Loading ...
Support Center